U.S. Oil and Gas Stock News

Carnival Corporation & (CCL) just reported record operating income of US$4.5b for fiscal 2025, reinstated a quarterly dividend of US$0.15 per share and plans to simplify its dual-listed structure into a single NYSE listing. See our latest analysis for Carnival Corporation &. At a share price of US$28.69, Carnival Corporation & has had mixed shorter term momentum, with a 30 day share price return of a 6.55% decline but a 90 day share price return of 2.94%. The 3 year total shareholder return...

If you are wondering whether Cummins' current share price lines up with its underlying value, this review will walk through what the numbers are saying and where the gaps might be. The stock last closed at US$576.23, with returns of 1.8% over 7 days, 11.0% over 30 days, 10.4% year to date, 67.8% over 1 year and 148.0% over 3 years, which may have changed how investors think about both upside and risk. Recent attention on Cummins has centered on its position in capital goods and the role its...

Joby Aviation (NYSE:JOBY) is pursuing legal action against Archer Aviation over alleged theft of confidential information by a former employee. The company has expanded its collaboration with Toyota, which is involved in supporting Joby’s electric air taxi program. Joby is working with Metropolis Technologies on vertiport rollout to support future urban air mobility operations. Joby Aviation focuses on electric vertical take off and landing aircraft, aiming to offer urban air taxi services...

Ellington Financial (NYSE:EFC) has announced a sizable underwritten public offering of common stock. The company plans to use the proceeds to redeem all outstanding shares of its Series A Preferred Stock. This transaction reflects a meaningful change in Ellington Financial's capital structure and dividend obligations. Ellington Financial focuses on investing in a mix of financial assets, so any shift in its capital structure can matter for how you think about risk, income, and balance sheet...

Wondering if StandardAero is priced fairly right now or if the market is missing something? This article explains what the current share price might be suggesting about its value. StandardAero shares recently closed at US$33.12, with returns of 3.4% over 7 days, 13.6% over 30 days, 11.7% year to date, and 27.2% over the last year, which may catch the eye of investors watching for changing risk and reward. Recent coverage around StandardAero has focused on its position in the capital goods...

If you are wondering whether Celldex Therapeutics at US$26.23 is priced attractively or asking too much for its potential, you are in the right place. The stock has returned 4.3% over the last 7 days, while the 1 year return sits at 6.5%, alongside more mixed figures of a 0.6% decline over 30 days, a 2.9% decline year to date, and a 40.5% decline over 3 years, with a 20.5% gain over 5 years. Recent news flow around Celldex has focused on its position within the pharmaceuticals and biotech...

Stride (NYSE:LRN) reported strong earnings results, with revenue and enrollment growth highlighted in its latest update. Career learning programs showed significant enrollment expansion, contributing to improved gross margins and operational efficiency. The company chose to prioritize long-term stability over rapid near-term expansion, including limiting new student intake where capacity is tight. Stride also exited a non-core business commitment, sharpening its focus on core education and...

If you have been wondering whether Terex stock is offering good value right now, the numbers behind its current price can tell you a lot about what you are really paying for. Terex recently closed at US$60.47, with returns of 2.5% over the last 7 days, 9.6% over the last month, 9.9% year to date and 30.3% over the last year, as well as 23.4% over 3 years and 76.6% over 5 years. These figures may shape how investors view both potential upside and risk today. Recent coverage around Terex has...

Danaher Corporation has released its full-year 2025 results, reporting sales of US$24.57 billion versus US$23.88 billion a year earlier, while net income eased to US$3.61 billion from US$3.90 billion and diluted earnings per share from continuing operations slipped to US$5.03 from US$5.29. The combination of higher sales but lower earnings suggests rising costs or mix pressures across Danaher’s portfolio at a time when investors had been focused on contributions from its Diagnostics, Life...

Despite an already strong run, Mirum Pharmaceuticals, Inc. ( NASDAQ:MIRM ) shares have been powering on, with a gain of...

The board of U.S. Global Investors, Inc. ( NASDAQ:GROW ) has announced that it will pay a dividend of $0.0075 per share...

As the U.S. stock market experiences a period of modest gains, with major indices like the S&P 500 reaching new milestones and investors anticipating key decisions from the Federal Reserve, attention turns to identifying opportunities within this evolving landscape. In such an environment, discerning undervalued stocks can be crucial for investors aiming to capitalize on potential market inefficiencies and intrinsic value disparities.

As the U.S. market experiences a slight uptick with major indices like the S&P 500 reaching new milestones, investors are keenly observing how upcoming Federal Reserve decisions and tech earnings will impact future trends. In this environment, growth companies with high insider ownership often attract attention, as their alignment of interests between insiders and shareholders can be appealing amid fluctuating market conditions.

As the U.S. stock market edges higher with the S&P 500 reaching new milestones, investors are keenly watching for signals from the Federal Reserve and major tech earnings that could influence future trends. Amidst this backdrop, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities for those seeking growth at lower price points. Though considered a niche area, these stocks can shine when backed by solid financial health and fundamentals,...

As the United States market navigates a period of cautious optimism with key indices like the S&P 500 reaching new heights, investors are closely watching for signals from the Federal Reserve and major tech earnings. Amidst this backdrop, small-cap stocks often present unique opportunities for those looking to explore lesser-known companies that could benefit from broader economic trends and sector-specific catalysts.

As the U.S. stock market continues to edge higher, with the S&P 500 reaching new milestones and investor attention focused on Federal Reserve decisions and major tech earnings, dividend stocks remain an attractive option for those seeking steady income amidst market fluctuations. In this environment, a good dividend stock is characterized by its ability to offer consistent payouts and financial stability, providing investors with a reliable income stream even as broader economic conditions...

InMode (NASDAQ:INMD) has had a great run on the share market with its stock up by a significant 10% over the last week...

Cornerstone Bancorp (CNBP) closed out FY 2025 with fourth quarter total revenue of US$11.0 million and basic EPS of US$3.14, alongside net income of US$3.09 million that capped off a year of steady profitability. The company has seen quarterly revenue move from US$9.66 million in Q4 FY 2024 to US$11.0 million in Q4 FY 2025, while basic EPS over that same period went from US$3.02 to US$3.14, supported by a trailing twelve month net profit margin of 25.9% versus 25.7% a year earlier. Taken...

Capricor Therapeutics recently issued a regulatory update on its Biologics License Application for Deramiocel in Duchenne muscular dystrophy, confirming that the FDA has requested the full Phase 3 HOPE-3 clinical study report and supporting data, but no new clinical trials or patient data. The absence of a request for additional studies, combined with Capricor’s plan to submit the HOPE-3 report in February 2026, places the focus squarely on data interpretation and the potential for a new...

If you are looking at Centene and wondering whether the current share price reflects its underlying value, this article will walk through the key numbers that matter most. The stock closed at US$41.53, with a 7 day return of 9.2% decline, a 30 day return of 2.5%, a year to date return of 0.6% decline, and a 1 year return of 35.8% decline, which may change how you think about both risk and upside. Recent news around Centene has focused on its position in managed care and how investors are...

If you are wondering whether Alexander's current share price still offers value, it helps to step back and look at what the recent returns and fundamentals are really telling you. The stock most recently closed at US$239.55, with a 7 day return of 0.5% decline, a 30 day return of 9.8%, year to date return of 9.5%, and a 1 year return of 36.3%, which naturally raises questions about how much of this is already reflected in the price. These moves sit alongside a 3 year return of 27.7% and a 5...

If you are wondering whether Chewy's current share price lines up with its true value, this article is designed to walk you through that question step by step. Chewy's shares last closed at US$31.30, with returns of a 5.1% decline over 7 days, a 3.7% decline over 30 days, a 6.5% decline year to date, a 19.5% decline over 1 year, a 30.5% decline over 3 years, and a 69.2% decline over 5 years. These figures may affect how investors are thinking about both risk and potential upside. Recent...

Over the past week, International Business Machines (NYSE:IBM) joined more than 100 organizations in supporting Open Invention Network's expanded OIN 2.0 patent protection and funding model for open source software. IBM announced new agentic AI collaborations with global partners, including e&, focused on real world use cases such as compliance and operational efficiency. The company also launched AI driven digital experiences for the GRAMMYs and introduced Enterprise Advantage, a generative...

If you are wondering whether Leidos Holdings at around US$187 per share still offers value after a strong run, this article will walk through what the current price might imply. The stock has delivered a 33.6% return over the past year and 96.3% over three years. More recently it has seen a 2.0% decline over 7 days and a 0.7% return over the last month, with a 2.0% return year to date. Investors have been paying close attention to Leidos because of its role as a major government and defense...